PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321

p53 Mutations in Human Cancers

Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651

Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor

Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

Interaction between Altered P53 and PTEN Inactivation has a biological predictive implication in assessment of aggressive breast cancer

Al-Kashwan, T. A. J., Al-Janabi, A. A. H., & Al-bideri, W. (2015) · Cited by 1

Lower endogenous p53 levels and degradation of AKT protein contribute to potent suppression of the new antibiotic Xiakemycin�A on tumor cells

Chen, C., Jiang, Z.-K., Ou, X., Zhang, H., Sun, C., & He, Q. (2018) · Oncology Reports · doi:10.3892/or.2018.6380 · Cited by 1

Altered regulation of PTEN by mutagenesis and p85 binding

Pastor, M. (2008) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1

Combined treatment of canine osteosarcoma cells with gene knock-down and chemotherapy

Gallienne, J. (2014) · The Atrium (University of Guelph) · Cited by 1

Molecular Genetics of Brain Tumors—An Overview

Demuth, T., & Berens, M. E. (2006) · Elsevier eBooks · doi:10.1016/b978-012088410-0/50046-9 · Cited by 1

Regulation of the p53 Response by Cellular Growth and Survival Factors

Brown, L. M., & Benchimol, S. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_5 · Cited by 1

Avaliação molecular do gene supressor de tumor PTEN em tumores do sistema nervoso

Custódio, A. C. (2006) · doi:10.11606/d.17.2006.tde-11062013-150806

Role of Immunohistochemical Expression of PTEN in Hepatocellular Carcinoma

Tai, M. (2005) · Handbook of immunohistochemistry and in situ hybridization of human carcinomas · doi:10.1016/s1874-5784(05)80022-4

Avaliação imunoistoquímica das proteínas metalotioneína, pAKT e NF-kB como marcadores de prognóstico de carcinomas epidermóides de boca

Pontes, H. A. R. (2008) · doi:10.11606/t.23.2008.tde-08042009-113006

Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7

Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)

Melanoma: Treatments and Resistance

Castillo, J., & Jasiulionis, M. G. (2013) · InTech eBooks · doi:10.5772/54202

THE INFLUENCE OF ZINC STATUS ON AKT SIGNALING PATHWAY IN HUMAN NORMAL PROSTATE EPITHELIAL CELLS AND HUMAN MALIGNANT PROSTATE CELLS

Han, T. (2007) · University Libraries (University of Maryland)

Correspondence re: M. V. Swamy et al. , Inhibition of COX-2 in Colon Cancer Cell Lines by Celecoxib Increases the Nuclear Localization of Active p53. Cancer Res 2003;63:5239–42.

Schönthal, A. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3145

Tissue biomarkers in cancer of the urinary bladder and kidney : High-throughput tissue microarrays in the study of urinary tract malignancies

Visapää, H. (2003) · Työväentutkimus Vuosikirja

Regulation of Cancer Cell Survival Mediated by Endogenous Tumor Suppression: A Dissertation

Guha, M. (2009) · eScholarship@UMassChan · doi:10.13028/n7fz-my84

A Short Thesis about Growth Factors in Gliomas

Hesselager, G. (2003) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Etude des mécanismes de mort cellulaire et de résis tance des cellules cancéreuses pour le développement de nouvelles approches thérapeutiques : modèle du mélanome

Paris-Sud, F. D. M., & Mayola, E. (2011)

The Role and Regulation of the Phosphatase PPM1D in Chemoresistant Gynecological Cancers

Ali, A. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3512

THE ATTENUATION OF THE P53 RESPONSE TO DNA DAMAGE IN RODENT LIVER PRENEOPLASTIC ENZYME- ALTERED FOCI

Finnberg, N. K. (2003) · Figshare

Análise da Via do Akt em Neoplasias Benignas e Malignas de Glândulas Salivares

Paulo, S. (2010)

Overview of the biochemical and genetic processes in malignant mesothelioma* Panorama dos processos bioquímicos e genéticos presentes no mesotelioma maligno

Vinícius, L., de Assis, M., & Isoldi, M. C. (2014)

p53 Regulates the Formation of Lamellipodia and Circular Dorsal Ruffles Through Caldesmon and PTEN

Vandenberg, L. (2011) · QSpace (Queen's University Library)

AVALIAÇÃO IMUNOISTOQUÍMICA DAS PROTEÍNAS METALOTIONEÍNA, pAKT e NF-κB COMO MARCADORES DE PROGNÓSTICO DE CARCINOMAS EPIDERMÓIDES DE BOCA

Paulo, S. (2008)

Polo-like kinase 1 as a prognostic and therapeutic target in high-grade brain tumors

Triscott, J. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0166568

Towards functional multiscale analysis of colorectal cancer

Briffa, R. (2014) · ERA

The evolution of p53 network behaviorPreprint

Sivakumar, H., Hespanha, J. P., Roh, K., & Proulx, S. R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/098376

Expression of P53, PTEN and S100A4 in invasive ductal breast cancer and the clinical significance

Gang, Z., Zhong, L., Xiao-meng, L., Jun-hua, Z., Yong, C., & Xing, Z. (2017) · Journal of Chitwan Medical College · doi:10.3126/jcmc.v6i2.16690

Panorama dos processos bioquímicos e genéticos presentes no mesotelioma maligno* Overview of the biochemical and genetic processes in malignant mesothelioma

Vinícius, L., de Assis, M., & Isoldi, M. C. (2014)

Towards the Investigation of the Effects of Nitration on the Activity of the Human p53 Tumour Suppressor Protein. Nitration of the p53 Tumour Suppressor Protein

Husaini, R. (2014) · Bradford Scholars (University of Bradford)

The Effect of Multidrug System on Treatment of Hepatocellular Carcinoma

Bassiouny, A. R., Hassan, A. Z., Ghonaim, T. M., & Mahmoud, F. A. (2017) · Biochemistry Letters · doi:10.21608/blj.2017.47600

Prostate Cancer

Febbo, P. G., & Kantoff, P. W. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00074-3

Modeling human prostate cancer development using transgenic mice with heterogeneous mutations

Kim, J. (2009)

R248Q mutation of p53 alters molecular trafficking and targeted drug responses in high-grade serous ovarian carcinomaPreprint

Tsai, K.-Y., Lai, Z., Chang, S., & Chuang, Y. (2019) · Research Square · doi:10.21203/rs.2.15415/v1

Drug penetration through the blood–brain barrier after radiotherapy: New approaches to bypass glioblastoma chemoresistance

Sardi, I., Guidi, M., Giunti, L., Iorio, A. L., Casati, G., Censullo, M. L., & Rombi, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00019-1

Phosphatase and tensin homolog deleted in chromosome 10

Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00014-x

Immunohistochemical Evaluation of the Relationship of PTEN Gene Expression and Pathological Parameters in Patients with Breast Cancer

Golmohammadi, R., Mojadadi, M., Pejhan, A., & Dastjerdi, M. N. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)

Consequences of Hypoxic Events, Necrosis, and Microvascular Density, in Astrocytoma IDH-Mutant, CNS WHO Grade 4

Orǎșanu, C. I., Boşoteanu, M., Vameşu, S., Vodă, R. I., Sincu, A., & Deacu, M. (2025) · Medical Sciences · doi:10.3390/medsci14010006

Endometrial Hyperplasia with Conservative Treatment Using the Progestin or EP Agents, Compared to Cases that Worsen during Observation

Niwa, K., Tsurue, S., Niwa, K., Hayasaki, Y., Isobe, M., & Tanaka, T. (2026) · Open Journal of Pathology · doi:10.4236/ojpathology.2026.161007

The Nuclear Face of PTEN : Implications in Cancer Prognosis and Targeted Therapy

Ghosh, M. K., Chakraborty, S., Karmakar, S., & BASU, M. N. (2026) · BioFactors · doi:10.1002/biof.70072

Fonctions de la protéine suppresseur de tumeurs PTEN : régulation par les β-arrestines et par l’interaction intramoléculaire

Lima‐Fernandes, E. (2012) · theses.fr (ABES) · doi:10.70675/dc75b7cbz5451z4999za5e5z58fe19782ff1

Etudes des mécanismes de mort cellulaire et résistance des cellules cancéreuses pour le développement de nouvelles approches thérapeutiques : modèle du mélanome

Mayola, E. (2011) · theses.fr (ABES) · doi:10.70675/2c0950e9zc6a5z4df5z8b22z699acecdcdf0

Contribution à l'étude du cycle de la cellule endothéliale cornéenne humaine

Pipparelli, A. (2010) · theses.fr (ABES) · doi:10.70675/75d922eaz27b5z4cc8zb0a0z5995152aa929

Identification des mécanismes moléculaires et cellulaires sous jacents à la perte de Pten dans l’épithélium prostatique murin et étude du rôle de la Vitamine D dans la carcinogenèse prostatique

Grelet, É. (2018) · theses.fr (ABES) · doi:10.70675/acc680a1zecfdz4c85z8f27z1fd05d90a500

Characterization of Pten and Trp53 deficient prostatic tumors in mice

Bizri, R. E. (2018) · theses.fr (ABES) · doi:10.70675/887a45dbz93f0z4790z9840z71a317de4d2f

Glioblastoma resistance to temozolomide : implication of α5β1 integrin and p53 signalling pathways

Sani, S. (2020) · theses.fr (ABES) · doi:10.70675/9566c585z0508z455bz9064z6bb61435b210

Développement de nouveaux inhibiteurs d'IRE1 pour le traitement adjuvant du glioblastome

Langlais, T. (2022) · doi:10.70675/04d81866z7572z4c43z8d41z45af019b2beb

AICAR induces S phase cell cycle arrest in ESCC by targeting the AMPK/mTORC1 and mTORC2/AKT pathway

Zou, M., Zhang, T., He, L., Li, J., Lin, Z., Jia, C., Ma, K., Wang, L., Xu, S., Bozhi, C., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1975805

BindingDB Entry 50002591: Novel 4-aminoquinazoline derivatives induce growth inhibition, cell cycle arrest and apoptosis via PI3Kα inhibition.

BindingDB (2020) · UC San Diego · doi:10.7270/q2gf0x3z

BindingDB Entry 50016746: Novel indole alpha-methylene-gamma-lactones as potent inhibitors for AKT-mTOR signaling pathway kinases.

BindingDB (2009) · UC San Diego · doi:10.7270/q2x63mgx

Laminin-1 mediates epigenetic control of the epithelial cadherin for breast cancer cells in three-dimensional culture

Benton, G. (2010) · DigitalGeorgetown (Georgetown University Library)

AVALIAÇÃO DA EXPRESSÃO PROTEICA DE PTEN, MDM2, P53 E AR EM LESÕES PROLIFERATIVAS DA PRÓSTATA CANINA

Calderón, R., & Gabriel, L. (2014) · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences

The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network

Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 419

PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.

Zhou, M., Gu, L., Findley, H. W., Jiang, R., & Woods, W. G. (2003) · PubMed · Cited by 120

Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors

Kitagishi, Y., Matsuda, S., Minami, A., Ono, Y., Nakanishi, A., & Ogura, Y. (2014) · Cancer Studies and Molecular Medicine - Open Journal · doi:10.17140/csmmoj-1-101 · Cited by 4

PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations

Li, Y., Guessous, F., Kwon, S., Kumar, M., Ibidapo, O., Fuller, L., Johnson, E., Lal, B., Hussaini, I., Bao, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1963 · Cited by 95

PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms

Freeman, D. J., Li, A. G., Wei, G., Li, H.-H., Kertesz, N. L., Lesche, R., Whale, A. D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R. D., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00021-7 · Cited by 512